The apolipoprotein E epsilon 4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations

Ann Neurol. 1994 Sep;36(3):434-7. doi: 10.1002/ana.410360315.

Abstract

In 31 symptomatic and 5 asymptomatic carriers of the amyloid precursor protein (APP) gene codon 693 mutation, 10 family members without mutation, and 5 carriers of the APP gene codon 692 mutation (3 with early-onset Alzheimer dementia, 2 with cerebral hemorrhage), a high frequency of the apolipoprotein E epsilon 4 allele was found. Age at onset, age at death, occurrence of dementia, and number of strokes did not differ between APP gene mutation carriers with or without epsilon 4 allele, showing that the clinical expression of these APP mutations is not influenced by the apolipoprotein E gene.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / genetics
  • Amyloid Neuropathies / genetics
  • Amyloid Neuropathies / pathology
  • Amyloid beta-Protein Precursor / genetics*
  • Apolipoproteins E / genetics*
  • Brain / pathology
  • Cerebral Hemorrhage / genetics
  • Cerebral Hemorrhage / pathology
  • Codon
  • Female
  • Genotype
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mutation / genetics*

Substances

  • Amyloid beta-Protein Precursor
  • Apolipoproteins E
  • Codon